Isolation and characterization of mesenchymal stem cells from whole human umbilical cord applying a single enzyme approach

Cell Biochemistry and Function

Volumn 30, Issue 8, 2012, Pages 643-649

  Zhang, Hao ^a,b   Zhang, Bin ^b   Tao, Yanling ^a   Cheng, Mei ^b   Hu, Jiangwei ^b   Xu, Man ^b   Chen, Hu ^b  

^a First Hospital of Harbin   (China)

^b BEIJING INSTITUTE OF MICROBIOLOGY AND EPIDEMIOLOGY   (China)

Author keywords

Differentiation; Enzyme digestion; Mesenchymal stem cells; Umbilical cord; Whole

Indexed keywords

5' NUCLEOTIDASE; CD34 ANTIGEN; CD45 ANTIGEN; ENDOGLIN; FATTY ACID BINDING PROTEIN 4; HLA DR ANTIGEN; OCTAMER TRANSCRIPTION FACTOR 4; OSTEOCALCIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; THY 1 ANTIGEN; TRANSCRIPTION FACTOR NANOG; TRANSCRIPTION FACTOR SOX2;

ADIPOCYTE; ANTIGEN EXPRESSION; ARTICLE; CARTILAGE CELL; CELL ADHESION; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL DIFFERENTIATION; CELL ISOLATION; CELL PROLIFERATION; CELL STRUCTURE; COLONY FORMING UNIT; DNA CONTENT; FIBROBLAST; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN TISSUE; MESENCHYMAL STEM CELL; MONONUCLEAR CELL; OSTEOCYTE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UMBILICAL CORD;

5'-NUCLEOTIDASE; ADIPOCYTES; ADULT; ANTIGENS, CD; ANTIGENS, THY-1; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SEPARATION; CELLS, CULTURED; CHONDROCYTES; FEMALE; FLOW CYTOMETRY; HOMEODOMAIN PROTEINS; HUMANS; MESENCHYMAL STROMAL CELLS; OCTAMER TRANSCRIPTION FACTOR-3; OSTEOCYTES; PLURIPOTENT STEM CELLS; RECEPTORS, CELL SURFACE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SOXB1 TRANSCRIPTION FACTORS; UMBILICAL CORD;

EID: 84870713832     PISSN: 02636484     EISSN: 10990844     Source Type: Journal    
DOI: 10.1002/cbf.2843     Document Type: Article

References (19)

1. Gnecchi M, Melo LG. Bone marrow-derived mesenchymal stem cells: isolation, expansion, characterization, viral transduction, and production of conditioned medium. Methods Mol Biol 2009; 482: 281-294.
2. Kode JA, Mukherjee S, Joglekar MV, et al. Mesenchymal stem cells: immunobiology and role in immunomodulation and tissue regeneration. Cytotherapy 2009; 11: 377-391.
3. Tomar GB, Srivastava RK, Gupta N, et al. Human gingiva-derived mesenchymal stem cells are superior to bone marrow-derived mesenchymal stem cells for cell therapy in regenerative medicine. Biochem Biophys Res Commun 2010; 393: 377-383.
4. Han ZC. Umbilical cord mesenchymal stem cells (UC-MSC: biology, banking and clinical applications). Bull Acad Natl Med 2009; 193: 545-547.
5. Lu LL, Liu YJ, Yang SG, et al. Isolation and characterization of human umbilical cord mesenchymal stem cells with hematopoiesis-supportive function and other potentials. Haematologica 2006; 91: 1017-1026.
6. Ishige I, Nagamura-Inoue T, Honda MJ, et al. Comparison of mesenchymal stem cells derived from arterial, venous, and Wharton's jelly explants of human umbilical cord. Int J Hematol 2009; l90: 261-269.
7. Majore I, Moretti P, Stahl F, et al. Growth and differentiation properties of mesenchymal stromal cell populations derived from whole human umbilical cord. Stem Cell Rev 2011; 7: 17-31.
8. La Rocca G, Anzalone R, Corrao S, et al. Isolation and characterization of Oct-4+/HLA-G+mesenchymal stem cells from human umbilical cord matrix: differentiation potential and detection of new markers. Histochem Cell Biol 2009; 131: 267-282.
9. Zeddou M, Briquet A, Relic B, et al. The umbilical cord matrix is a better source of mesenchymal stem cells (MSC) than the umbilical cord blood. Cell Biol Int 2010; 34: 693-701.
10. Digirolamo CM, Stokes D, Colter D, et al. Propagation and senescence of human marrow stromal cells in culture: a simple colony-forming assay identifies samples with the greatest potential to propagate and differentiate. Br J Haematol 1999; 107: 275-281.
11. Abdallah BM, Kassem M. Human mesenchymal stem cells: from basic biology to clinical applications. Gene Ther 2008; 15: 109-116.
12. Kadner A, Zund G, Maurus C, et al. Human umbilical cord cells for cardiovascular tissue engineering: a comparative study. Eur J Cardiothorac Surg 2004; 25: 635-641.
13. Romanov YA, Svintsitskaya VA, Smirnov VN, et al. Searching for alternative sources of postnatal human mesenchymal stem cells: candidate MSC-like cells from umbilical cord. Stem Cells 2003; 21: 105-110.
14. Sarugaser R, Lickorish D, Baksh D, et al. Human umbilical cord perivascular (HUCPV) cells: a source of mesenchymal progenitors. Stem Cells 2005; 23: 220-229.
15. Jiang Y, Jahagirdar BN, Reinhardt RL, et al. Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 2002; 418: 41-49.
16. Dominici M, Le Blanc K, Mueller I, et al. Minimal criteria for defining multipotent mesenchymal stem cells. The International Society for Cellular Therapy position statement. Cytotherapy 2006; 8: 315-317.
17. Pittenger MF, Mackay AM, Beck SC, et al. Multilineage potential of adult human mesenchymal stem cells. Science 1999; 284: 143-147.
18. Campagnoli C, Roberts IA, Kumar S, et al. Identification of mesenchymal stem cell/progenitor cells in human first-trimester fetal blood, liver, and bone marrow. Blood 2001; 98: 2396-2402.
19. Digirolamo CM, Stokes D, Colter D, et al. Optimization of culture conditions to support undifferentiated growth of human embryonic stem cells. Cell Reprogram 2010; 12: 305-314.